Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.08% sank 0.46% to $164.94 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.12% falling 0.21% to 3,647.29 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% falling 0.43% to 29,134.99. This was the stock's second consecutive day of losses. Johnson & Johnson closed $21.75 below its 52-week high ($186.69), which the company reached on April 25th.
The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +3.76% rose 1.74% to $313.14, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.22% fell 0.39% to $85.84, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.33% rose 0.59% to $44.09. Trading volume (8.6 M) eclipsed its 50-day average volume of 7.1 M.